You are here: Home » International » News » Others
Business Standard

Germany coronavirus update: 22,609 new Covid cases take tally to 855,916

Germany has recorded 22,609 fresh coronavirus cases, taking the tally in the country to 855,916, the Robert Koch Institute (RKI) said

Coronavirus | Germany | Coronavirus Tests

IANS  |  Berlin 

Coronavirus testing
Coronavirus testing

has recorded 22,609 fresh cases, taking the tally in the country to 855,916, the Robert Koch Institute (RKI) said.

The increase is slightly above the previous week's level.

is currently in the second half of a month-long partial lockdown, Xinhua news agency reported.

The situation is "still serious, very serious," said RKI President Lothar Wieler at a press conference on Thursday. The case numbers are "still very high overall, much too high."

"The case numbers have stabilized at a high level in the last two weeks," said Wieler.

"But we do not know whether this is already a trend reversal."

The number of deaths related to COVID-19 in increased by 251 on Thursday to a total of 13,370, according to the RKI.

The number of Covid-19 patients in intensive care increased to 3,561 by Wednesday, the RKI said. During the first wave of COVID-19, the peak was around 2,900 Covid-19 patients in intensive care units, according to the DIVI online registry for intensive care beds.

Some hospitals in the country could reach capacity limits soon and patients could no longer receive optimal care, Wieler said.

On Monday, Chancellor Angela Merkel and the minister presidents of the federal states drew up an interim balance sheet of Germany's partial lockdown. Rather than further tightening the preventive measures, they appealed to the public to reduce social contacts to a minimum.

As the world is struggling to contain the pandemic, countries including Germany, China, Russia, the United Kingdom and the United States are racing to find a vaccine.

According to the website of the World Health Organization, as of November 12, 212 Covid-19 candidate vaccines were being developed worldwide, 48 of them in clinical trials.



(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, November 20 2020. 07:05 IST